title: The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit.
abstract: Melanoma is a highly metastatic cancer, and there are no current therapeutic modalities to treat this deadly malignant disease once it has metastasized. Melanoma cancers exhibit B-RAF mutations in up to 70% of cases. B-RAF mutations are responsible, in large part, for the constitutive hyperactivation of survival/antiapoptotic pathways such as the MAPK, NF-κB, and PI3K/AKT. These hyperactivated pathways regulate the expression of genes targeting the initiation of the metastatic cascade, namely, the epithelial to mesenchymal transition (EMT). EMT is the result of the expression of mesenchymal gene products such as fibronectin, vimentin, and metalloproteinases and the invasion and inhibition of E-cadherin. The above pathways cross-talk and regulate each other's activities and functions. For instance, the NF-κB pathway directly regulates EMT through the transcription of gene products involved in EMT and indirectly through the transcriptional up-regulation of the metastasis inducer Snail. Snail, in turn, suppresses the expression of the metastasis suppressor gene product Raf kinase inhibitor protein RKIP (inhibits the MAPK and the NF-κB pathways) as well as PTEN (inhibits the PI3K/AKT pathway). The role of B-RAF mutations in melanoma and their direct role in the induction of EMT are not clear. This review discusses the hypothesis that B-RAF mutations are involved in the dysregulation of the NF-κB/Snail/RKIP/PTEN circuit and in both the induction of EMT and metastasis. The therapeutic implications of the dysregulation of the above circuit by B-RAF mutations are such that they offer novel targets for therapeutic interventions in the treatment of EMT and metastasis.
authors.affiliation: Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Lin
authors.forename: Stavroula
authors.initials: S
authors.lastname: Baritaki
authors.forename: Loredana
authors.initials: L
authors.lastname: Militello
authors.forename: Graziella
authors.initials: G
authors.lastname: Malaponte
authors.forename: Ylenia
authors.initials: Y
authors.lastname: Bevelacqua
authors.forename: Benjamin
authors.initials: B
authors.lastname: Bonavida
references.citation: Br J Cancer. 2006 Sep 4;95(5):581-6
references.pmid: 16880785
references.citation: Nat Rev Mol Cell Biol. 2004 Nov;5(11):875-85
references.pmid: 15520807
references.citation: J Transl Med. 2009 Oct 14;7:86
references.pmid: 19828018
references.citation: J Biol Chem. 1998 May 29;273(22):13375-8
references.pmid: 9593664
references.citation: Nature. 2006 Jan 19;439(7074):358-62
references.pmid: 16273091
references.citation: Onkologie. 2008 Jul;31(7):398-403
references.pmid: 18596389
references.citation: Cancer J Sci Am. 2000 Feb;6 Suppl 1:S11-4
references.pmid: 10685652
references.citation: EMBO J. 2001 Jul 16;20(14):3716-27
references.pmid: 11447113
references.citation: Curr Biol. 2005 Feb 8;15(3):249-54
references.pmid: 15694309
references.citation: Curr Opin Pharmacol. 2008 Aug;8(4):419-26
references.pmid: 18644254
references.citation: Cancer Res. 2003 Jul 15;63(14):3883-5
references.pmid: 12873977
references.citation: Oncogene. 2008 Apr 3;27(15):2243-8
references.pmid: 17952120
references.citation: J Biol Chem. 2004 Jul 23;279(30):31769-79
references.pmid: 15145934
references.citation: Cancer Invest. 2008 Jun;26(5):516-34
references.pmid: 18568775
references.citation: J Clin Invest. 2004 Aug;114(4):569-81
references.pmid: 15314694
references.citation: Biochim Biophys Acta. 2009 Dec;1796(2):293-308
references.pmid: 19683560
references.citation: J Invest Dermatol. 2008 Nov;128(11):2575-2595
references.pmid: 18927540
references.citation: Oncogene. 2007 Mar 22;26(13):1954-8
references.pmid: 17001349
references.citation: Mol Cell Biol. 2001 Nov;21(21):7207-17
references.pmid: 11585904
references.citation: Hematol Oncol Clin North Am. 2009 Jun;23(3):529-45, ix
references.pmid: 19464601
references.citation: Mol Cell Biol. 2008 Mar;28(5):1528-40
references.pmid: 18172008
references.citation: FEBS Lett. 2008 Jun 11;582(13):1821-8
references.pmid: 18472007
references.citation: Mol Cancer Res. 2006 Nov;4(11):803-10
references.pmid: 17077165
references.citation: J Cutan Pathol. 2007 Mar;34(3):220-5
references.pmid: 17302605
references.citation: Cancer Res. 2001 Jun 15;61(12):4901-9
references.pmid: 11406569
references.citation: Endocr Rev. 2001 Apr;22(2):153-83
references.pmid: 11294822
references.citation: Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2366s-2370s
references.pmid: 16609060
references.citation: J Biol Chem. 2001 Jul 6;276(27):24661-6
references.pmid: 11323412
references.citation: Science. 1997 Mar 28;275(5308):1943-7
references.pmid: 9072974
references.citation: J Cell Biol. 1995 Nov;131(3):791-805
references.pmid: 7593197
references.citation: J Clin Oncol. 1996 Jan;14(1):7-17
references.pmid: 8558223
references.citation: Biochim Biophys Acta. 2007 Aug;1773(8):1299-310
references.pmid: 17188374
references.citation: Biochem J. 2004 Aug 15;382(Pt 1):1-11
references.pmid: 15193142
references.citation: Curr Opin Genet Dev. 1998 Feb;8(1):49-54
references.pmid: 9529605
references.citation: Nat Genet. 2003 Jan;33(1):19-20
references.pmid: 12447372
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Cell. 1989 Jul 28;58(2):227-9
references.pmid: 2665943
references.citation: J Biol Chem. 1995 Jan 6;270(1):269-73
references.pmid: 7814385
references.citation: Pigment Cell Melanoma Res. 2009 Aug;22(4):400-19
references.pmid: 19493313
references.citation: Cancer Cell. 2004 Oct;6(4):313-9
references.pmid: 15488754
references.citation: Methods Enzymol. 2008;439:25-38
references.pmid: 18374154
references.citation: Cancer Res. 2009 Nov 1;69(21):8376-85
references.pmid: 19843864
references.citation: J Biol Chem. 1994 Oct 28;269(43):26602-5
references.pmid: 7929388
references.citation: Cancer Metastasis Rev. 2005 Jun;24(2):273-85
references.pmid: 15986137
references.citation: J Cell Sci. 2003 May 15;116(Pt 10):1959-67
references.pmid: 12668723
references.citation: Anticancer Res. 2001 Nov-Dec;21(6B):4207-19
references.pmid: 11908674
references.citation: J Am Acad Dermatol. 1998 May;38(5 Pt 1):716-30
references.pmid: 9591817
references.citation: Nat Genet. 1998 Aug;19(4):348-55
references.pmid: 9697695
references.citation: J Biol Chem. 2004 Apr 23;279(17):17515-23
references.pmid: 14766752
references.citation: Oncogene. 2004 Sep 23;23(44):7345-54
references.pmid: 15286702
references.citation: Clin Cancer Res. 2002 Dec;8(12):3728-33
references.pmid: 12473582
references.citation: Nature. 2002 Jun 27;417(6892):949-54
references.pmid: 12068308
references.citation: J Exp Med. 2009 Jan 16;206(1):221-32
references.pmid: 19124656
references.citation: J Cell Sci. 2004 Apr 1;117(Pt 9):1675-85
references.pmid: 15075229
references.citation: J Biol Chem. 2001 Jun 1;276(22):18934-40
references.pmid: 11259436
references.citation: Nat Cell Biol. 2000 Feb;2(2):76-83
references.pmid: 10655586
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3537-42
references.pmid: 9520401
references.citation: Cancer Cell. 2002 Oct;2(4):275-8
references.pmid: 12398891
references.citation: Oncogene. 2005 May 12;24(21):3535-40
references.pmid: 15782137
references.citation: N Engl J Med. 2006 Jul 6;355(1):51-65
references.pmid: 16822996
references.citation: Cancer Cell. 2005 Dec;8(6):443-54
references.pmid: 16338658
references.citation: Mol Biol Cell. 1995 Jul;6(7):841-50
references.pmid: 7579698
references.citation: Int J Oncol. 2009 Jun;34(6):1481-9
references.pmid: 19424565
references.citation: Science. 1994 Sep 2;265(5177):1458-61
references.pmid: 8073291
references.citation: J Natl Cancer Inst. 1999 Nov 3;91(21):1820-8
references.pmid: 10547389
references.citation: Cell. 2004 Mar 19;116(6):855-67
references.pmid: 15035987
references.citation: Invest Ophthalmol Vis Sci. 2010 Jan;51(1):421-9
references.pmid: 19661225
references.citation: Cancer Res. 2005 Nov 15;65(22):10164-9
references.pmid: 16288000
references.citation: J Invest Dermatol. 2008 Aug;128(8):2003-12
references.pmid: 18323787
references.citation: Curr Oncol Rep. 2010 May;12(3):146-52
references.pmid: 20425073
references.citation: J Biol Chem. 2003 Sep 5;278(36):34548-54
references.pmid: 12821662
references.citation: J Biol Chem. 1993 Oct 5;268(28):20701-4
references.pmid: 8407889
references.citation: Cancer Biol Ther. 2006 Sep;5(9):1065-73
references.pmid: 16969122
references.citation: Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1047-57
references.pmid: 19029025
references.citation: J Natl Cancer Inst. 2003 Jun 18;95(12):878-89
references.pmid: 12813171
references.citation: J Clin Oncol. 2001 Aug 15;19(16):3635-48
references.pmid: 11504745
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:918-28
references.pmid: 19273108
references.citation: J Biol Chem. 2002 Mar 8;277(10):7920-8
references.pmid: 11773061
references.citation: EMBO J. 2000 Oct 16;19(20):5429-39
references.pmid: 11032810
references.citation: Adv Exp Med Biol. 2008;624:104-16
references.pmid: 18348451
references.citation: Pigment Cell Melanoma Res. 2010 Feb;23(1):41-56
references.pmid: 19843243
references.citation: Cancer Res. 2006 Aug 15;66(16):7833-6
references.pmid: 16912153
references.citation: Oncogene. 1998 Jul 2;16(26):3397-402
references.pmid: 9692547
references.citation: Adv Cancer Res. 2009;102:19-65
references.pmid: 19595306
references.citation: Arch Surg. 1991 Apr;126(4):438-41
references.pmid: 2009058
references.citation: Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10148-52
references.pmid: 7937853
references.citation: Cell Signal. 2008 Jan;20(1):1-9
references.pmid: 17706925
references.citation: Nat Genet. 1997 Apr;15(4):356-62
references.pmid: 9090379
references.citation: Cancer Res. 2004 May 15;64(10):3428-35
references.pmid: 15150094
references.citation: Int J Oncol. 2003 Apr;22(4):891-8
references.pmid: 12632084
references.citation: J Natl Cancer Inst. 2010 Feb 24;102(4):214-5
references.pmid: 20145213
references.citation: J Cell Sci. 2002 Jan 1;115(Pt 1):141-51
references.pmid: 11801732
references.citation: Cancer Metastasis Rev. 2005 Jun;24(2):301-13
references.pmid: 15986139
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5246-50
references.pmid: 9560261
references.citation: Br J Cancer. 2004 Mar 22;90(6):1265-73
references.pmid: 15026811
references.citation: Cancer Res. 2002 Dec 1;62(23):6997-7000
references.pmid: 12460918
references.citation: Genes Dev. 1999 Nov 15;13(22):2905-27
references.pmid: 10579998
references.citation: Cancer Res. 2008 May 1;68(9):3429-39
references.pmid: 18451171
references.citation: Nature. 1999 Sep 9;401(6749):173-7
references.pmid: 10490027
references.citation: Nat Genet. 2009 May;41(5):544-52
references.pmid: 19282848
references.citation: Cancer Res. 2003 Dec 1;63(23):8132-7
references.pmid: 14678966